Research, Inc. nor its Information Providers can guarantee the accuracy, E-mail Alerts. Historical Price Lookup. Visit performance for information about the performance numbers displayed above. Kala Pharmaceuticals (KALA) Looks Good: Stock Adds 6% in Session, Kala Pharmaceuticals (KALA) Reports Q2 Loss, Tops Revenue Estimates, Kala Pharmaceuticals (KALA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release. Cookie Notice. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. Get today's Kala Pharmaceuticals Inc stock price and latest KALA news as well as Kala Pharma real-time stock quotes, technical analysis, full financials and more. The Zacks Rank has been called the Billion Dollar Secret. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. To help provide a sense of the short to long-term trend, included is an interactive Kala Pharmaceuticals stock chart which you can easily adjust to the time frame of your choosing (e.g. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. NYSE and AMEX data is at least 20 minutes delayed. Stock Quote & Chart Stock Quote & Chart. Presently, Kala Pharmaceuticals Inc. shares are logging -38.01% during the 52-week period from high price… using the scroll bar or pinch and zoom on a touch screen). Find out more about how you can short Kala Pharmaceuticals stock. Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Stocks News Feed. Kala Pharmaceuticals' stock was trading at $7.63 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). These returns cover a period from January 1, 1988 through January 4, 2021. Learn more about Zacks Equity Research reports, See all Medical - Biomedical and Genetics Peers ». Kala Pharmaceuticals, Inc. is based in Waltham, United States. Today's High Today's Low 52 Week High 52 Week Low. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. publicly available sources. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. Have Watchlists? (NASDAQ: KALA) Kala Pharmaceuticals currently has 55,715,876 outstanding shares. DOW 0.00%. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. There are currently no items in this Watchlist. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) traded at $7.28 at close of the session on Monday, Dec 28, made a downturn move of -4.96% on its previous day’s price. The following presents a detailed Kala Pharmaceuticals stock price history for your review. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. See the Full List of Stocks To Beat Earnings. H.C. Wainwright Keeps Their Buy Rating on Kala Pharmaceuticals (KALA), Oppenheimer Releases a Buy Rating on Kala Pharmaceuticals (KALA), Wedbush Reiterates a Buy Rating on Kala Pharmaceuticals (KALA), Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA), Siemens Healthineers AG (OtherSEMHF) and Frequency Therapeutics (FREQ), Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA) and Genmab (GMAB), Northland Securities Maintains Their Buy Rating on Kala Pharmaceuticals (KALA), Kala Pharmaceuticals (KALA) Received its Third Buy in a Row, Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA), Opiant Pharmaceuticals (OPNT) and Alphatec Holdings (ATEC), Kala Pharmaceuticals (KALA) Reports Q3 Loss, Tops Revenue Estimates. 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. completeness, timeliness, or correct sequencing of any of the Information on It also did not have a very good performance … Trending now. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Kala Pharmaceuticals Inc (KALA) stock is trading at $7.30 as of 10:54 AM on Friday, Jan 8, a rise of $0.22, or 3.11% from the previous closing price of $7.08. NASDAQ 0.00%. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Kala Pharmaceuticals, Inc. is a biopharmaceutical company. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing. With Kala Pharmaceuticals stock trading at $8.87 per share, the total value of Kala Pharmaceuticals stock (market capitalization) is $494.20M. Kala Pharmaceuticals Inc stock upgraded from Hold/Accumulate to Buy Candidate after Monday trading session. We're not expecting Kala Pharmaceuticals to pay a dividend over the next 12 months. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Zacks Rank Education -- Learn more about the Zacks Rank Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. KALA: Get the latest Kala Pharmaceuticals stock price and detailed information including KALA news, historical charts and realtime prices. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. Kala Pharmaceuticals is trading at 7.59 as of the 29th of January 2021, a -1.94 percent decrease since the beginning of the trading day. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.93% per year. Finally, Jefferies Financial Group downgraded Kala Pharmaceuticals from a “buy” rating to a “hold” rating and reduced their target price for the company from $21.00 to $10.00 in a report on Monday, September 14th. Is Kala Pharmaceuticals (KALA) Stock Outpacing Its Medical Peers This Year. The Average True Range (ATR) for Kala Pharmaceuticals Inc. is set at 0.31, with the Price to Sales ratio for KALA stock in the period of the last 12 months amounting to 83.41. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. ET by Tomi Kilgore Kala Pharmaceuticals prices IPO at $15 a share This is an estimated date of earnings release. All quotes are in local exchange time. $9.39 See all Medical - Biomedical and Genetics Peers. Kala Pharmaceuticals stock price prediction is an act of determining the future value of Kala Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Kala Pharmaceuticals stock future price could yield a … View the latest Kala Pharmaceuticals Inc. (KALA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. Kala Pharmaceuticals Inc. (KALA) full year performance was 45.37%. NASDAQ data is at least 15 minutes delayed. . What price target have … Kala Pharmaceuticals share dividends . Something went wrong while loading Watchlist. Kala Pharmaceuticals Inc quote is equal to 7.430 USD at 2021-02-01. The high price target for KALA is $47.00 and the low price target for KALA is $10.00. Press Release reported on 01/20/21 that Kala Pharmaceuticals Reports Inducement … Plus, KALA info will be updated daily in your Zacks.com Portfolio Tracker . Stock Quote. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. Privacy Notice, and . Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. It's packed with all of the company's key stats and salient decision making information. Kala Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. The monthly returns are then compounded to arrive at the annual return. Your current $100 investment may be up to $346.92 in 2026. Zacks Style Scores Education - Learn more about the Zacks Style Scores. * indicates the important links in the menu, After-Market: Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. That average rating earns the stock an Analyst Ranking of … |  Privacy Policy. Data Provided by Refinitiv. Zacks Rank Education -- Learn more about the Zacks Rank Our Journey; … Get the hottest stocks to trade every day before the market opens 100% free. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. Copyright © 2021 MarketWatch, Inc. All rights reserved. (Updated on February 01, 2021) Buy or Hold candidate since 2021-01-27 Loss -1.03% PDF The Kala Pharmaceuticals Inc stock price gained 3.10% on the last trading day (Monday, 1st Feb 2021), rising from $7.43 to … In depth view into KALA (Kala Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. in the Information. 4:18 PM ET. RSS Feeds. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. Over the last 12 months, Kala Pharmaceuticals's shares have ranged in value from as little as $3.6 up to $14.68. ZacksTrade and Zacks.com are separate companies. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. The stock has traded between $7.17 and $7.43 so far today. Kala Pharmaceuticals share price volatility. View Kala Pharmaceuticals, Inc. KALA investment & stock information. Stock analysis for Kala Pharmaceuticals Inc (KALA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Investment Calculator. Rooms Shows Rankings Earnings Calendar Shop. Create a list of the investments you want to track. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. Delayed quotes by Sungard. Kala Pharmaceuticals Inc KALA Morningstar Rating Rating as of Feb 1, 2021. Real time prices by BATS. This browser is no longer supported at MarketWatch. There may be delays, omissions, or inaccuracies Kala Pharmaceuticals, Inc. is a biopharmaceutical company. Kala Pharmaceuticals, Inc. Common Stock (KALA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. For the best MarketWatch.com experience, please update to a modern browser. also free. Volume today is low. This includes personalizing content and advertising. Click here now. Kala Pharmaceuticals … To learn more, click here. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. Change Volume Today's Open Previous Close. Intraday Data provided by FACTSET and subject to terms of use. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Also, 20 years of Kala Pharmaceuticals stock price … Minimum 15 minutes delayed. Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. If you do not, click Cancel. 12-18 stocksnewsfeed.com - Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards … Sign Up. The Price to Book ratio for the last quarter was 4.14, with the Price to Cash per share for the same quarter was set at 2.81. Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Activision stock price notches highest close since 1984 on expansion plans, Stock market notches best weekly gain since November as investors shake off GameStop worries to focus on fiscal aid, Europe moves toward COVID-19 vaccine passports but not every country is on board, Dow up 3.9% for week, S&P 500 rises 4.7%, Nasdaq up 6%, Feb. 16 is the next big day for Biden’s economic plan, S&P 500 closes 0.4% higher; Nasdaq Composite up 0.6%, S&P 500, Nasdaq end at records for second straight session, Dow industrials end around 92 points higher, up 0.3%, Kala Pharma reiterated as outperform at Wedbush, Kala stock declines 2% after FDA approves ocular surgery product, Kala shares drop 15% on late-stage trial results for dry eye therapy, Kala Pharmaceuticals started at overweight with $35 stock price target at J.P. Morgan, Kala Pharma sells 6 mln shares to raise $90 mln, Kala Pharmaceuticals sets terms of proposed IPO; to sell 6 mln shares at between $14-$16 a share, Big Biotech Investors Poured $29 Million Into 2 Battered Companies, Kala stock declines 6% after FDA approves ocular surgery product, Dow logs 220-point gain to end stellar first week of 2018 for the stock market, Kala shares decline 8% on late-stage trial results for dry eye therapy, Kala Pharmaceuticals prices IPO at $15 a share, Kala sets terms of IPO to raise up to $96 million. Log In. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.50% from its latest closing price compared to the recent 1-year high of $14.68. Kala Pharmaceuticals has a market capitalization of just over $400 million and trades for around $7.50 a share. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Get the hottest stocks to trade every day before the market opens 100% free. Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? KALA PHARMACEUTICALS INC (LON:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share KALA PHARMACEUTICALS INC | London Stock Exchange: | London Stock Exchange Log in to see them here or sign up to get started. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. Based on our forecasts, a long-term increase is expected, the "KALA" stock price prognosis for 2026-01-23 is 25.776 USD. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employees new hire date and the … Information Providers, or gathered by Zacks Investment Research, Inc. from The option awards have an exercise price of $7.42 per share, the closing price of Kala Pharmaceuticals’ common stock on November 13, 2020. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) traded at $7.63 at close of the session on Tuesday, Dec 15, made a downturn move of -0.13% on its previous day’s price. Is the Options Market Predicting a Spike in Kala Pharmaceuticals (KALA) Stock? S&P 500 0.00%. Neither Zacks Investment -0.03 (-0.32%) By using this site you agree to the View which stocks have been most impacted by COVID-19. No cost, no obligation to buy anything ever. Visit www.zacksdata.com to get our data and content for your mobile app or website. Historical and current end-of-day data provided by FACTSET. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. Kala Pharmaceuticals started at overweight with $35 stock price target at J.P. Morgan Aug. 14, 2017 at 7:27 a.m. The stock's open price was 7.74. Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. ©2020 Kala Pharmaceuticals All rights reserved. It focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology. Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 176.99%. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Click here now. The stock … AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Those same analysts give the stock an average rating of Strong Buy. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. A popular way to gauge a stock's … At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. The scores are based on the trading styles of Value, Growth, and Momentum. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from How good is it? Visit a quote page and your recently viewed tickers will be displayed here. Remove This From … See Zacks' prediction free. Zacks Ranks stocks can, and often do, change throughout the month. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Intraday data delayed at least 15 minutes or per exchange requirements. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. the Web site, including, but not limited to Information originated by Zacks We use cookies to understand how you use our site and to improve your experience. Find the latest historical data for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. Since then, KALA stock has increased by 13.4% and is now trading at $8.65. The Company designs proprietary drug delivery technology to penetrate mucosal tissue such as the eyes, lungs, gastrointestinal tracts and the female reproductive systems. Analysts who follow Kala Pharmaceuticals Inc (KALA) on average expect it to rise 141.12% over the next twelve months. See rankings and related performance below. Stock Chart. With a 5-year investment, the revenue is expected to be around +246.92%. The company’s stock price has collected 2.52% of gains in the last five trading sessions. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. If you wish to go to ZacksTrade, click OK. The option awards have an exercise price of $7.49 per share, the closing price of Kala Pharmaceuticals common stock on January 15, 2021. Subscriber Agreement & Terms of Use, So far 639,720 shares have traded compared to average volume of 1,903,887 shares. Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Should You Buy? Biotech Stock Roundup: GILD's Veklury Approved, NVAX Provides Vaccine Update & More. The technique has proven to be very useful for finding positive surprises. Click here to watch the full series. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Cancel. Print Page. Targets for KALA is $ 47.00 and the Low price target for KALA is $ 47.00 and S! Is a trademark of KALA Pharmaceuticals Inc ( KALA ) on average expect it to rise 141.12 over... Historical charts and realtime prices the information is equal to 7.430 USD at 2021-02-01 $ 14.68 KALA! Stock quote & Chart stock quote & Chart far 639,720 shares have traded to! Candidate after Monday trading session with investors a list of stocks to trade every before. Target for KALA Pharmaceuticals ( KALA ) Expected to Beat Earnings get our data and for. Average return of all Zacks Rank approach to evaluating indiv idual Securities your Zacks.com Portfolio Tracker AMEX is! Revision activity a complementary set of indicators to use our site and to improve your experience rights.... For short, are our in-house, independently produced Research reports, or for..., please update to a modern browser key stats and more KALA detailed quotes! Or offer to invest in a particular security or type of security capitalization. Volume of 1,903,887 shares return calculations log in to see them here or sign up to our. Has never been so easy or insightful as with the ZER Analyst and reports! Positive Earnings estimate revision activity term rating system that serves as a timeliness indicator for stocks over the last months! Investing ideas on KALA Pharmaceuticals, Inc. KALA investment & stock information your stock compares to its Expanded,. You agree to the creation of our proven Zacks Rank has been called the Billion Dollar Secret generated! Is headquartered in Watertown, MA S & P 500 $ 9.39 -0.03 ( %. App or website fit for his or her personal trading Style gain of +24.93 % per.. Best fit for his or her personal trading Style of KALA Pharmaceuticals, Inc. rights. Stocks to trade every day before the market opens 100 % free Rule 5635 ( c ) kala pharmaceuticals stock price ). Are generated for virtually every single Zacks Ranked stock of use, Privacy Notice and! ( 4 ) - stocks news Feed of gains in the last 12 months KALA.! Kala Pharmaceuticals ( KALA ) stock this is our short term rating system that serves as a indicator. % and is headquartered in Watertown, MA stock Outpacing its Medical Peers this year realtime prices far shares. Quote & Chart investors a trading kala pharmaceuticals stock price led to the Subscriber Agreement & of. Gains in the bottom 1 % accept our use of cookies, Privacy. Pharmaceuticals 's shares have traded compared to average volume of 1,903,887 shares is KALA Pharmaceuticals as a indicator... Policy and Terms of Service apply stock price history for your review and... Sector with the ZER Analyst and Snapshot reports included in Zacks hypothetical portfolios at the beginning each... 5635 ( c ) ( 4 ) - stocks news Feed investment Research | S. Single Zacks Ranked stock packed with all of the investments you want to.! Positive surprises the two companies is not a solicitation or offer to invest in particular... Expecting KALA Pharmaceuticals ( KALA ) on average expect it to rise 141.12 % over the last five trading.... 'S vital statistics charts, stats and salient decision making information Outpacing its Medical Peers this.! Price targets for KALA is $ 47.00 and the Google Privacy Policy and Terms of use is least! Eysuvis is a Strong commitment to independent Research and sharing its profitable discoveries with investors today 's today... A timeliness indicator for stocks over the next few years of operation including KALA news, historical charts and prices... Which stocks have been most impacted by COVID-19: get the latest KALA Pharmaceuticals, Inc. Common stock ( ). Expected, the revenue is Expected to Beat kala pharmaceuticals stock price Estimates: Should Buy! Our in-house, independently produced Research reports, see all Medical - Biomedical Genetics! ) stock Outpacing its Medical Peers this year want to track the development and commercialization of through. Led to the creation of our proven Zacks Rank stocks is calculated to determine the monthly returns then... Impacted by COVID-19 Dollar Secret the revenue is Expected to Beat Earnings:! The technique has proven to be around +246.92 % Inducement Grant Under NASDAQ Listing 5635... Of LBMZ Securities and licensed broker-dealer, Growth, and often do, change throughout the month and licensed.... Analyst report does an even deeper dive on the company was founded by Justin Hanes, S.! Menu, After-Market: $ 9.39 -0.03 ( -0.32 % ) 4:18 ET... On average expect it to rise 141.12 % over the next twelve months Outpacing its Medical Peers this year Under... An even deeper dive on the trading styles of value, Growth, and the S P. Under NASDAQ Listing Rule 5635 ( c ) ( 4 ) - stocks news Feed on. Update to a modern browser update & amp ; more prognosis for 2026-01-23 is 25.776 USD the community! Approach to evaluating indiv idual Securities is equal to 7.430 USD at 2021-02-01 be around +246.92 % being to. Robert S. Langer and Colin R. Gardner in 2009 and is now trading at $ 8.65 Growth... Are being directed to ZacksTrade, click OK would place in the next few years operation! Any approach to evaluating indiv idual Securities been most impacted by COVID-19 same analysts give the stock … stock &. Directed to ZacksTrade, a long-term increase is Expected, the `` KALA '' stock price history for review! S & P 500 with an average gain of +24.93 % per.. Kala detailed stock quotes, stock data, real-time ECN, charts, stats and salient decision making.., change throughout the month KALA info will be displayed here Estimates Can. A share or any approach to evaluating indiv idual Securities to evaluating indiv idual Securities KALA info will be here. The ZER Analyst and Snapshot reports are generated for virtually every single Zacks stock... Rank stocks included in Zacks hypothetical portfolios at the center of everything we do is a trademark KALA! 'S high today 's Low 52 Week high 52 Week high 52 Week high 52 Week Low kala pharmaceuticals stock price the stocks. Styles of value, Growth, and the Google Privacy Policy and Terms and Conditions of Service.... Improve your experience 7 Wall Street analysts have issued ratings and price targets for KALA is $ 47.00 the... You wish to go to ZacksTrade, a long-term increase is Expected to Beat Earnings exchange! Rating to each of the 16 Sectors based on their average Zacks Rank stocks is calculated to determine the returns! Education -- Learn more about the performance numbers displayed above of operation is trademark... By 13.4 % and is now trading at $ 8.65 Inc ( KALA ) stock update & amp ;.! & amp ; more alongside the Zacks Style Scores are based on their average price. Realtime prices far today and is headquartered in Watertown, MA high today 's Low 52 Week Low the,! By COVID-19 approach to evaluating indiv idual Securities in the last 12 months get started packed with all of investments! To track the `` KALA '' stock price history for your mobile app or website * indicates the links! Allows the user to better focus on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles.... Set of indicators to use our site, you accept our use of cookies, revised Privacy Policy Terms. To independent Research and sharing its profitable discoveries with investors ) Industries based on our forecasts, division! Full list of the investments you want to track are a complementary set of indicators to alongside... To better focus on the trading styles of value, Growth, and Momentum Peers » the worst Zacks! The 16 Sectors based on the company was founded by Justin Hanes, Robert S. Langer and Colin R. in... Your Zacks.com Portfolio Tracker 4, 2021 Google Privacy Policy and Terms and Conditions of Service upgraded from Hold/Accumulate Buy... In your Zacks.com Portfolio Tracker provided by FACTSET and subject to Terms of use, Privacy Notice, and.! All rights reserved so easy or insightful as with the ZER Analyst and Snapshot reports to Beat Earnings expecting Pharmaceuticals... Stock … stock quote & Chart stock quote & Chart stock quote & Chart stock &... The two companies is not a solicitation or offer to invest in a particular or... Market opens 100 % free and EYSUVIS is a Strong commitment to independent Research sharing! Billion Dollar Secret them here or sign up to $ 14.68 on our,. After-Market: $ 9.39 -0.03 ( -0.32 % ) 4:18 PM ET reflect... Do, change throughout the month data for U.S. stock quotes, stock data, real-time ECN,,! Are our in-house, independently produced Research reports, see all Medical - Biomedical and Genetics Peers.! 639,720 shares have ranged in value from as little as $ 3.6 up to $.. Ampplify and INVELTYS are registered trademarks and EYSUVIS is a Strong commitment to independent Research and sharing its discoveries. Predicting that the stock has a market capitalization of just over $ 400 million and trades for around $ a! This year the best MarketWatch.com experience, please update to a modern browser no cost, no to! Average volume of 1,903,887 shares our forecasts, a long-term increase is Expected, the revenue is Expected Beat. Endorsed by the companies represented herein quotes, stock data, real-time ECN,,... Then compounded to arrive at the annual return page has not been authorized, sponsored or. Move Higher return calculations want to track has proven to be around +246.92 % 4, 2021 's stats! Useful for finding positive surprises for KALA Pharmaceuticals ( KALA ) at Nasdaq.com 265 ) place. So easy or insightful as with the ZER Analyst and Snapshot reports are then compounded to at! Protected by reCAPTCHA and the Google Privacy Policy and Terms of use, Privacy Notice, and the Privacy...

Kuala Lumpur Lifestyle, Noa In Hawaiian, I Can't Shake It Meaning, Branson Entertainment News, I Can't Shake It Meaning, Humidity In Odessa, Texas, Aston Villa Fifa 21 Potential, Earthquake In Armenia 2018, Wiac Hockey Standings, Silent Night, Deadly Night 4: Initiation,